Fc proteoforms of ACPA IgG discriminate autoimmune responses in plasma and synovial fluid of rheumatoid arthritis patients and associate with disease activity

Constantin Blöchl,Eva Maria Stork,Hans Ulrich Scherer,Rene E. M. Toes,Manfred Wuhrer,Elena Domínguez-Vega

DOI: https://doi.org/10.1101/2024.04.04.587930

2024-04-06

Abstract:Autoantibodies and their post-translational modifications (PTMs) are insightful markers of autoimmune diseases providing diagnostic and prognostic clues, thereby informing clinical decisions. However, current autoantibody analyses focus mostly on IgG1 glycosylation representing only a subpopulation of the actual IgG proteome. Here, by taking rheumatoid arthritis (RA) as prototypic autoimmune disease, we sought to circumvent these shortcomings and illuminate the importance of (auto)antibody proteoforms employing a novel comprehensive mass spectrometry (MS)-based analytical workflow. Profiling of anti-citrullinated protein antibodies (ACPA) IgG and total IgG in paired samples of plasma and synovial fluid revealed a clear distinction of autoantibodies from total IgG and between biofluids. This discrimination relied on comprehensive subclass-specific PTM profiles including previously neglected features such as IgG3 C 3 domain glycosylation, allotype ratios, and non-glycosylated IgG. Intriguingly, specific proteoforms were found to correlate with markers of inflammation and disease accentuating the need of such approaches in clinical investigations and calling for further mechanistic studies to comprehend the role of autoantibody proteoforms in defining autoimmune responses.

Immunology

What problem does this paper attempt to address?

This paper aims to solve the following problems:

1. **Limitations of current autoantibody analysis**: Current autoantibody analysis mainly focuses on IgG1 glycosylation, which represents only a part of the actual IgG proteome. This limitation may lead to insufficient understanding of the diversity of autoantibodies in autoimmune diseases.

2. **Importance of comprehensive analysis of autoantibody protein forms**: By adopting a new comprehensive analysis workflow based on mass spectrometry (MS), the researchers hope to overcome the above limitations and reveal the importance of (auto)antibody protein forms in distinguishing autoimmune responses in plasma and synovial fluid.

Specifically, the paper addresses these problems through the following methods:

- **Sample processing and autoantibody capture**: Purify anti - citrullinated protein antibody (ACPA) IgG and total IgG from paired plasma and synovial fluid samples of rheumatoid arthritis (RA) patients.
- **Mass spectrometry analysis**: Use nano - scale high - performance liquid chromatography - mass spectrometry (nano HPLC - MS) technology to analyze the Fc parts of these IgGs to obtain detailed protein form characteristics, including glycosylation, isotype ratios, and other post - translational modifications (PTMs).
- **Data analysis**: Compare the differences in IgG subclasses and their glycosylation in different samples by statistical methods such as principal component analysis (PCA), especially the differences between ACPA and total IgG, as well as the differences between plasma and synovial fluid.

The study found that specific protein forms are associated with inflammatory markers and disease activity, emphasizing the need for such comprehensive analysis in clinical research and calling for further mechanistic studies to understand the role of autoantibody protein forms in defining autoimmune responses.